Proteotype launches Alchemi, a €499k EIC‑backed data‑orchestration platform to unify lab and clinical data across borders
Executive summary: Proteotype unveiled Alchemi, a data and orchestration platform funded by roughly €499,000 from the EIC Pre‑Accelerator, aimed at linking laboratory measurements, multi‑country clinical data and healthcare workflows. By enabling secure, interoperable data exchange across distributed labs, Alchemi could reduce manual data‑integration costs and improve the efficiency of multinational clinical trials and research collaborations.
Who is involved: Proteotype (developer), the European Innovation Council Pre‑Accelerator (funding source), and targeted laboratories in multiple countries (intended users).
Likely next: Further platform development and pilot deployments with European hospital labs, followed by pursuit of additional funding or commercial partnerships to scale the solution.
Proteotype’s announcement reveals that the Alchemi platform has received approximately €499,000 from the European Innovation Council Pre‑Accelerator to connect laboratory measurements, multi‑country clinical data and healthcare workflows. The solution is positioned to enable secure, interoperable deployment across distributed laboratories, addressing a persistent fragmentation in health‑data infrastructure. While still early‑stage, the funding and clear use‑case suggest a potential pathway for scaling cross‑border health‑data exchanges in Europe.
Timeline
- — Proteotype Unveils Alchemi®, the Data and Orchestration Platform Behind Enlighten® (PR Newswire)